Role of ATP-binding cassette (ABC) transporters in interactions between natural products and drugs

Current Drug Metabolism

Volumn 9, Issue 10, 2008, Pages 1010-1018

  Aszalos, Adorjan ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Breast cancer resistance protein; Flavonoids; Food drug interactions; Multidrug resistance protein; Mycotoxins; P glycoprotein

Indexed keywords

3 INDOLEMETHANOL; ABC TRANSPORTER; AURANTIIN; CHRYSIN; CYCLOSPORIN A; DAUNORUBICIN; DEXTROMETHORPHAN; DIGOXIN; DILTIAZEM; DOXORUBICIN; ELACRIDAR; FELODIPINE; FLAVONOID; FUMONISIN B1; GALLIC ACID; HERBACEOUS AGENT; HUANG LIAN JIE DU TANG; MORIN; MYCOTOXIN; NATURAL PRODUCT; NIMODIPINE; QUERCETIN; RHODAMINE 123; TALINOLOL; TERFENADINE; TOPOTECAN; UNCLASSIFIED DRUG; UNINDEXED DRUG; VERAPAMIL; VINCRISTINE; VITEXIN 2' O RHAMNOSIDE; ABCG2 PROTEIN, HUMAN; GLYCOPROTEIN P; MULTIDRUG RESISTANCE PROTEIN; MULTIDRUG RESISTANCE PROTEIN 1; MULTIDRUG RESISTANCE PROTEIN 2; MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 1; MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 2; TUMOR PROTEIN;

APOPTOSIS; AREA UNDER THE CURVE; BLOOD BRAIN BARRIER; CELL MEMBRANE; CHEMICAL ANALYSIS; CONCENTRATION RESPONSE; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG HYDROLYSIS; DRUG MECHANISM; DRUG POTENTIATION; FLOW CYTOMETRY; FOOD; FOOD DRUG INTERACTION; FRUIT JUICE; GRAPEFRUIT JUICE; HUMAN; MAXIMUM PLASMA CONCENTRATION; MODULATION; NONHUMAN; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN GLYCOSYLATION; PROTEIN METHYLATION; PROTEIN STRUCTURE; REVIEW; STOMACH CARCINOMA; WASABI; GRAPEFRUIT; PHYSIOLOGY;

ATP-BINDING CASSETTE TRANSPORTERS; CITRUS PARADISI; FOOD-DRUG INTERACTIONS; HUMANS; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; NEOPLASM PROTEINS; P-GLYCOPROTEIN;

EID: 62749188875     PISSN: 13892002     EISSN: None     Source Type: Journal    
DOI: 10.2174/138920008786927776     Document Type: Review

References (73)

1. Gottesman, M.M.; Pastan, I. Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu. Rev. Biochem., 1993, 62, 385-427.
2. Zhang, J.T. The multi-structural feature of the multidrug resistance gene product P-glycoprotein: implications for its mechanism of action (hypothesis). Mol. Membr. Biol., 2001, 18(2), 145-152.
3. Sharom, F.J. Shedding light on drug transport: structure and function of the P-glycoprotein multidrug transporter (ABCB1). Biochem. Cell. Biol., 2006, 84(6), 979-992.
4. Kitagawa, S.; Nabekura, T.; Kamiyama, S.; Takahashi, T.; Nakamura, Y.; Kashiwada, Y.; Ikeshiro, Y. Effects of alkyl gallates on P-glycoprotein function. Biochem. Pharmacol., 2005, 70(8), 1262-1266.
5. Nabekura, T.; Kamiyama, S.; Kitagawa, S. Effects of dietary chemopreventive phytochemicals on P-glycoprotein function. Biochem. Biophys. Res. Commun., 2005, 327(3), 866-870.
6. De Angelis, I.; Frigge, G.; Raimondi, F.; Stammati, A.; Zucco, F.; Caloni, F. Absorption of fumonisin B1 and aminopentol on an in vitro model of intestinal epithelium; the role of P-glycoprotein. Toxicon., 2005, 45(3), 285-291.
7. Wang, J.; Xia, Y.; Wang, H.; Hou, Z. Chinese herbs of Shenghe Powder reverse multidrug resistance of gastric carcinoma SGC-7901. Integr. Cancer Ther., 2007, 6(4), 400-404.
8. Zhang, D.M.; He, Z.W.; Liu, X.D.; Li, Y.; Xie, L.; Wang, G.J.; Liu, L. In-vivo and in-vitro studies on the effect of Huang-Lian-Jie-Du-Tang on nimodipine transport across rat blood-brain barrier. J. Pharm. Pharmacol., 2007, 59(12), 1733-1738.
9. Di Pietro, A.; Conseil, G.; Perez-Victoria, J.M.; Dayan, G.; Baubichon-Cortay, H.; Trompier, D.; Steinfels, E.; Jault, J.M.; de Wet, H.; Maitrejean, M.; Comte, G.; Boumendjel, A.; Mariotte, A.M.; Dumontet, C.; McIntosh, D.B.; Goffeau, A.; Castanys, S.; Gamarro, F.; Barron, D. Modulation by flavonoids of cell multidrug resistance mediated by P-glycoprotein and related ABC transporters. Cell. Mol. Life Sci., 2002, 59(2), 307-322.
10. Mertens-Talcott, S.U.; De Castro, W.V.; Manthey, J.A.; Derendorf, H.; Butterweck, V. Polymethoxylated flavones and other phenolic derivates from citrus in their inhibitory effects on P-glycoprotein-mediated transport of talinolol in Caco-2 cells. J. Agric. Food Chem., 2007, 55(7), 2563-2568.
11. Ohtani, H.; Ikegawa, T.; Honda, Y.; Kohyama, N.; Morimoto, S.; Shoyama, Y.; Juichi, M.; Naito, M.; Tsuruo, T.; Sawada, Y. Effects of various methoxyflavones on vincristine uptake and multidrug resistance to vincristine in P-gp-overexpressing K562/ADM cells. Pharm. Res., 2007, 24(10), 1936-1943.
12. Takanaga, H.; Ohnishi, A.; Yamada, S.; Matsuo, H.; Morimoto, S.; Shoyama, Y.; Ohtani, H.; Sawada, Y. Polymethoxylated flavones in orange juice are inhibitors of P-glycoprotein but not cytochrome P450 3A4. J. Pharmacol. Exp. Ther., 2000, 293(1), 230-236.
13. Morris, M.E.; Zhang, S. Flavonoid-drug interactions: effects of flavonoids on ABC transporters. Life Sci., 2006, 78(18), 2116-2130.
14. Shapiro, A.B.; Ling, V. Effect of quercetin on Hoechst 33342 transport by purified and reconstituted P-glycoprotein. Biochem. Pharmacol., 1997, 53(4), 587-596.
15. Critchfield, J.W.; Welsh, C.J.; Phang, J.M.; Yeh, G.C. Modulation of adriamycin accumulation and efflux by flavonoids in HCT-15 colon cells. Activation of P-glycoprotein as a putative mechanism. Biochem. Pharmacol., 1994, 48(7), 1437-1445.
16. Castro, A.F.; Altenberg, G.A. Inhibition of drug transport by genistein in multidrug-resistant cells expressing P-glycoprotein. Biochem. Pharmacol., 1997, 53(1), 89-93.
17. Jodoin, J.; Demeule, M.; Beliveau, R. Inhibition of the multidrug resistance P-glycoprotein activity by green tea polyphenols. Biochim. Biophys. Acta, 2002, 1542(1-3), 149-159.
18. Mitsunaga, Y.; Takanaga, H.; Matsuo, H.; Naito, M.; Tsuruo, T.; Ohtani, H.; Sawada, Y. Effect of bioflavonoids on vincristine transport across blood-brain barrier. Eur. J. Pharmacol., 2000, 395(3), 193-201.
19. Zhang, S.; Morris, M.E. Effects of the flavonoids biochanin A, morin, phloretin, and silymarin on P-glycoprotein-mediated transport. J. Pharmacol. Exp. Ther., 2003, 304(3), 1258-1267.
20. Scambia, G.; Ranelletti, F.O.; Panici, P.B.; De Vincenzo, R.; Bonanno, G.; Ferrandina, G.; Piantelli, M.; Bussa, S.; Rumi, C.; Cianfriglia, M. et al. Quercetin potentiates the effect of adriamycin in a multidrug-resistant MCF-7 human breast-cancer cell line: P-glycoprotein as a possible target. Cancer Chemother. Pharmacol., 1994, 34(6), 459-464.
21. Eagling, V.A.; Profit, L.; Back, D.J. Inhibition of the CYP3A4-mediated metabolism and P-glycoprotein-mediated transport of the HIV-1 protease inhibitor saquinavir by grapefruit juice components. Br. J. Clin. Pharmacol., 1999, 48(4), 543-552.
22. Xu, Y.A.; Fan, G.; Gao, S.; Hong, Z. Assessment of intestinal absorption of vitexin-2″-o-rhamnoside in hawthorn leaves flavonoids in rat using in situ and in vitro absorption models. Drug Dev. Ind. Pharm., 2008, 34(2), 164-170.
23. Spahn-Langguth, H.; Langguth, P. Grapefruit juice enhances intestinal absorption of the P-glycoprotein substrate talinolol. Eur. J. Pharm. Sci., 2001, 12(4), 361-367.
24. Choi, J.S.; Han, H.K. Enhanced oral exposure of diltiazem by the concomitant use of naringin in rats. Int. J. Pharm., 2005, 305(1-2), 122-128.
25. Edwards, D.J.; Fitzsimmons, M.E.; Schuetz, E.G.; Yasuda, K.; Ducharme, M.P.; Warbasse, L.H.; Woster, P.M.; Schuetz, J.D.; Watkins, P. 6′,7′-Dihydroxybergamottin in grapefruit juice and Seville orange juice: effects on cyclosporine disposition, enterocyte CYP3A4, and P-glycoprotein. Clin. Pharmacol. Ther., 1999, 65(3), 237-244.
26. Di Marco, M.P.; Edwards, D.J.; Wainer, I.W.; Ducharme, M.P. The effect of grapefruit juice and seville orange juice on the pharmacokinetics of dextromethorphan: the role of gut CYP3A and P-glycoprotein. Life Sci., 2002, 71(10), 1149-1160.
27. Zhang, S.; Wang, X.; Sagawa, K.; Morris, M.E. Flavonoids chrysin and benzoflavone, potent breast cancer resistance protein inhibitors, have no significant effect on topotecan pharmacokinetics in rats or mdr1a/1b (-/-) mice. Drug Metab. Dispos., 2005, 33(3), 341-348.
28. Becquemont, L.; Verstuyft, C.; Kerb, R.; Brinkmann, U.; Lebot, M.; Jaillon, P.; Funck-Brentano, C. Effect of grapefruit juice on digoxin pharmacokinetics in humans. Clin. Pharmacol. Ther., 2001, 70(4), 311-316.
29. de Castro, W.V.; Mertens-Talcott, S.; Derendorf, H.; Butterweck, V. Effect of grapefruit juice, naringin, naringenin, and bergamottin on the intestinal carrier-mediated transport of talinolol in rats. J. Agric. Food Chem., 2008, 56(12), 4840-4845.
30. Ross, S.A.; Ziska, D.S.; Zhao, K.; ElSohly, M.A. Variance of common flavonoids by brand of grapefruit juice. Fitoterapia, 2000, 71(2), 154-161.
31. Rau, S.E.; Bend, J.R.; Arnold, M.O.; Tran, L.T.; Spence, J.D.; Bailey, D.G. Grapefruit juice-terfenadine single-dose interaction: magnitude, mechanism, and relevance. Clin. Pharmacol. Ther., 1997, 61(4), 401-409.
32. Ibrahim, S.; Peggins, J.; Knapton, A.; Licht, T.; Aszalos, A. Influence of beta-adrenergic antagonists, H1-receptor blockers, analgesics, diuretics, and quinolone antibiotics on the cellular accumulation of the anticancer drug, daunorubicin: P-glycoprotein modulation. Anticancer Res., 2001, 21(2A), 847-856.
33. Lundahl, J.; Regardh, C.G.; Edgar, B.; Johnsson, G. Effects of grapefruit juice ingestion - pharmacokinetics and haemodynamics of intravenously and orally administered felodipine in healthy men. Eur. J. Clin. Pharmacol., 1997, 52(2), 139-145.
34. Josefsson, M.; Zackrisson, A.L.; Ahlner, J. Effect of grapefruit juice on the pharmacokinetics of amlodipine in healthy volunteers. Eur. J. Clin. Pharmacol., 1996, 51(2), 189-193.
35. Sica, D.A. Interaction of grapefruit juice and calcium channel blockers. Am. J. Hypertens., 2006, 19(7), 768-773.
36. Yee, G.C.; Stanley, D.L.; Pessa, L.J.; Dalla Costa, T.; Beltz, S.E.; Ruiz, J.; Lowenthal, D.T. Effect of grapefruit juice on blood cyclosporin concentration. Lancet, 1995, 345(8955), 955-956.
37. Kantola, T.; Kivisto, K.T.; Neuvonen, P.J. Grapefruit juice greatly increases serum concentrations of lovastatin and lovastatin acid. Clin. Pharmacol. Ther., 1998, 63(4), 397-402.
38. Lilja, J.J.; Kivisto, K.T.; Neuvonen, P.J. Grapefruit juice-simvastatin interaction: effect on serum concentrations of simvastatin, simvastatin acid, and HMG-CoA reductase inhibitors. Clin. Pharmacol. Ther., 1998, 64(5), 477-483.
39. Bailey, D.G.; Arnold, J.M.; Munoz, C.; Spence, J.D. Grapefruit juice - felodipine interaction: mechanism, predictability, and effect of naringin. Clin. Pharmacol. Ther., 1993, 53(6), 637-642.
40. Ducharme, M.P.; Warbasse, L.H.; Edwards, D.J. Disposition of intravenous and oral cyclosporine after administration with grapefruit juice. Clin. Pharmacol. Ther., 1995, 57(5), 485-491.
41. Fuhr, U.; Maier-Bruggemann, A.; Blume, H.; Muck, W.; Unger, S.; Kuhlmann, J.; Huschka, C.; Zaigler, M.; Rietbrock, S.; Staib, A.H. Grapefruit juice increases oral nimodipine bioavailability. Int. J. Clin. Pharmacol. Ther., 1998, 36(3), 126-132.
42. Kiani, J.; Imam, S.Z. Medicinal importance of grapefruit juice and its interaction with various drugs. Nutr. J., 2007, 6, 33.
43. Borst, P.; Evers, R.; Kool, M.; Wijnholds, J. A family of drug transporters: the multidrug resistance-associated proteins. J. Natl. Cancer Inst., 2000, 92(16), 1295-1302.
44. Leslie, E.M.; Mao, Q.; Oleschuk, C.J.; Deeley, R.G.; Cole, S.P. Modulation of multidrug resistance protein 1 (MRP1/ABCC1) transport and atpase activities by interaction with dietary flavonoids. Mol. Pharmacol., 2001, 59(5), 1171-1180.
45. Nguyen, H.; Zhang, S.; Morris, M.E. Effect of flavonoids on MRP1-mediated transport in Panc-1 cells. J. Pharm. Sci., 2003, 92(2), 250-257.
46. van Zanden, J.J.; Wortelboer, H.M.; Bijlsma, S.; Punt, A.; Usta, M.; Bladeren, P.J.; Rietjens, I.M.; Cnubben, N.H. Quantitative structure activity relationship studies on the flavonoid mediated inhibition of multidrug resistance proteins 1 and 2. Biochem. Pharmacol., 2005, 69(4), 699-708.
47. Leslie, E.M.; Deeley, R.G.; Cole, S.P. Toxicological relevance of the multidrug resistance protein 1, MRP1 (ABCC1) and related transporters. Toxicology, 2001, 167(1), 3-23.
48. Konig, J.; Nies, A.T.; Cui, Y.; Leier, I.; Keppler, D. Conjugate export pumps of the multidrug resistance protein (MRP) family: localization, substrate specificity, and MRP2-mediated drug resistance. Biochim. Biophys. Acta, 1999, 1461(2), 377-394.
49. Jager, W.; Gehring, E.; Hagenauer, B.; Aust, S.; Senderowicz, A.; Thalhammer, T. Biliary excretion of flavopiridol and its glucuronides in the isolated perfused rat liver: role of multidrug resistance protein 2 (Mrp2). Life Sci., 2003, 73(22), 2841-2854.
50. van Zanden, J.J.; van der Woude, H.; Vaessen, J.; Usta, M.; Wortelboer, H.M.; Cnubben, N.H.; Rietjens, I.M. The effect of quercetin phase II metabolism on its MRP1 and MRP2 inhibiting potential. Biochem. Pharmacol., 2007, 74(2), 345-351.
51. Honda, Y.; Ushigome, F.; Koyabu, N.; Morimoto, S.; Shoyama, Y.; Uchiumi, T.; Kuwano, M.; Ohtani, H.; Sawada, Y. Effects of grapefruit juice and orange juice components on P-glycoprotein-and MRP2-mediated drug efflux. Br. J. Pharmacol., 2004, 143(7), 856-864.
52. Videmann, B.; Tep, J.; Cavret, S.; Lecoeur, S. Epithelial transport of deoxynivalenol: involvement of human P-glycoprotein (ABCB1) and multidrug resistance-associated protein 2 (ABCC2). Food Chem. Toxicol., 2007, 45(10), 1938-1947.
53. Pestka, J.J.; Smolinski, A.T. Deoxynivalenol: toxicology and potential effects on humans. J. Toxicol. Environ. Health B Crit. Rev., 2005, 8(1), 39-69.
54. Meky, F.A.; Turner, P.C.; Ashcroft, A.E.; Miller, J.D.; Qiao, Y.L.; Roth, M.J.; Wild, C.P. Development of a urinary biomarker of human exposure to deoxynivalenol. Food Chem. Toxicol., 2003, 41(2), 265-273.
55. Sundstol Eriksen, G.; Pettersson, H. Lack of de-epoxidation of type B trichothecenes in incubates with human faeces. Food Addit. Contam., 2003, 20(6), 579-582.
56. Berger, V.; Gabriel, A.F.; Sergent, T.; Trouet, A.; Larondelle, Y.; Schneider, Y.J. Interaction of ochratoxin A with human intestinal Caco-2 cells: possible implication of a multidrug resistance-associated protein (MRP2). Toxicol. Lett., 2003, 140-141, 465-476.
57. Suzuki, M.; Suzuki, H.; Sugimoto, Y.; Sugiyama, Y. ABCG2 transports sulfated conjugates of steroids and xenobiotics. J. Biol. Chem., 2003, 278(25), 22644-22649.
58. Ross, D.D.; Karp, J.E.; Chen, T.T.; Doyle, L.A. Expression of breast cancer resistance protein in blast cells from patients with acute leukemia. Blood, 2000, 96(1), 365-368.
59. Cooray, H.C.; Blackmore, C.G.; Maskell, L.; Barrand, M.A. Localisation of breast cancer resistance protein in microvessel endothelium of human brain. Neuroreport, 2002, 13(16), 2059-2063.
60. Maliepaard, M.; Scheffer, G.L.; Faneyte, I.F.; van Gastelen, M.A.; Pijnenborg, A.C.; Schinkel, A.H.; van De Vijver, M.J.; Scheper, R.J.; Schellens, J.H. Subcellular localization and distribution of the breast cancer resistance protein transporter in normal human tissues. Cancer Res., 2001, 61(8), 3458-3464.
61. Jonker, J.W.; Buitelaar, M.; Wagenaar, E.; Van Der Valk, M.A.; Scheffer, G.L.; Scheper, R.J.; Plosch, T.; Kuipers, F.; Elferink, R.P.; Rosing, H.; Beijnen, J.H.; Schinkel, A.H. The breast cancer resistance protein protects against a major chlorophyll-derived dietary phototoxin and protoporphyria. Proc. Natl. Acad. Sci. U. S. A., 2002, 99(24), 15649-15654.
62. Taipalensuu, J.; Tornblom, H.; Lindberg, G.; Einarsson, C.; Sjoqvist, F.; Melhus, H.; Garberg, P.; Sjostrom, B.; Lundgren, B.; Artursson, P. Correlation of gene expression of ten drug efflux proteins of the ATP-binding cassette transporter family in normal human jejunum and in human intestinal epithelial Caco-2 cell monolayers. J. Pharmacol. Exp. Ther., 2001, 299(1), 164-170.
63. Zhang, S.; Yang, X.; Morris, M.E. Flavonoids are inhibitors of breast cancer resistance protein (ABCG2)-mediated transport. Mol. Pharmacol., 2004, 65(5), 1208-1216.
64. Imai, Y.; Tsukahara, S.; Asada, S.; Sugimoto, Y. Phytoestrogens/ flavonoids reverse breast cancer resistance protein/ABCG2-mediated multidrug resistance. Cancer Res., 2004, 64(12), 4346-4352.
65. Setchell, K.D.; Brown, N.M.; Desai, P.; Zimmer-Nechemias, L.; Wolfe, B.E.; Brashear, W.T.; Kirschner, A.S.; Cassidy, A.; Heubi, J.E. Bioavailability of pure isoflavones in healthy humans and analysis of commercial soy isoflavone supplements. J. Nutr., 2001, 131(4 Suppl), 1362S-1375S.
66. Brand, W.; van der Wel, P.A.; Rein, M.J.; Barron, D.; Williamson, G.; van Bladeren, P.J.; Rietjens, I.M. Metabolism and transport of the citrus flavonoid hesperetin in Caco-2 cell monolayers. Drug Metab. Dispos., 2008, 36(9):1794-1802.
67. Ji, Y.; Morris, M.E. Effect of organic isothiocyanates on breast cancer resistance protein (ABCG2)-mediated transport. Pharm. Res., 2004, 21(12), 2261-2269.
68. Aszalos, A. Drug-drug interactions affected by the transporter protein, P-glycoprotein (ABCB1, MDR1) II. Clinical aspects. Drug Discov. Today, 2007, 12(19-20), 838-843.
69. Brand, W.; Schutte, M.E.; Williamson, G.; van Zanden, J.J.; Cnubben, N.H.; Groten, J.P.; van Bladeren, P.J.; Rietjens, I.M. Flavonoid-mediated inhibition of intestinal ABC transporters may affect the oral bioavailability of drugs, food-borne toxic compounds and bioactive ingredients. Biomed. Pharmacother., 2006, 60(9), 508-519.
70. Durr, D.; Stieger, B.; Kullak-Ublick, G.A.; Rentsch, K.M.; Steinert, H.C.; Meier, P.J.; Fattinger, K. St John's Wort induces intestinal Pglycoprotein/MDR1 and intestinal and hepatic CYP3A4. Clin. Pharmacol. Ther., 2000, 68(6), 598-604.
71. Glaeser, H.; Bailey, D.G.; Dresser, G.K.; Gregor, J.C.; Schwarz, U.I.; McGrath, J.S.; Jolicoeur, E.; Lee, W.; Leake, B.F.; Tirona, R.G.; Kim, R.B. Intestinal drug transporter expression and the impact of grapefruit juice in humans. Clin. Pharmacol. Ther., 2007, 81(3), 362-370.
72. Bailey, D.G.; Dresser, G.K.; Leake, B.F.; Kim, R.B. Naringin is a major and selective clinical inhibitor of organic anion-transporting polypeptide 1A2 (OATP1A2) in grapefruit juice. Clin. Pharmacol. Ther., 2007, 81(4), 495-502.
73. Dresser, G.K.; Bailey, D.G.; Leake, B.F.; Schwarz, U.I.; Dawson, P.A.; Freeman, D.J.; Kim, R.B. Fruit juices inhibit organic anion transporting polypeptide-mediated drug uptake to decrease the oral availability of fexofenadine. Clin. Pharmacol. Ther., 2002, 71(1), 11-20.